Rapoport, Bernardo Leon; Shannon, Vickie R.; Cooksley, Tim; Johnson, Douglas B.; Anderson, Lindsay; Blidner, Ada Gabriela; Tintinger, Gregory Ronald; Anderson, Ronald
(Frontiers Media, 2021-10)
The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer
treatment, with agents such as nivolumab, pembrolizumab, and cemiplimab targeting
programmed cell death protein-1 (PD-1) and durvalumab, ...
